Quinazoline and Quinoline Derivatives
Quinazolines and quinolines are nitrogen-containing heterocyclic compounds with aromatic structures that play a key role in the synthesis of drugs with anticancer, antimicrobial, and anti-inflammatory activity. Their derivatives feature structural modifications that optimise bioavailability and selectivity, enabling the development of new active ingredients for various therapeutic applications. These compounds are used in the manufacture of APIs for the treatment of cancer, infections, neurodegenerative diseases, and cardiovascular conditions. Additionally, quinazoline and quinoline derivatives are essential in the research of enzyme inhibitors and the design of innovative bioactive molecules.
At CymitQuimica, we offer high-purity quinazoline and quinoline derivatives for applications in chemical synthesis, pharmaceutical development, and biotechnology.
Found 65630 products of "Quinazoline and Quinoline Derivatives"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Dechloro-Rivaroxaban
CAS:Controlled Product<p>Applications Dechloro-Rivaroxaban is an impurity of Rivaroxaban (R538000), which is a novel antithrombotic agent. A highly potent and selective, direct FXa inhibitor.<br>References Ansell, J., et al.: Drugs, 64, 1 (2004), Eriksson, B., et al.: J. Thromb. Haemost., 3, 103 (2005), Kubitza, D., et al.: Clin. Pharmacol. Ther., 78, 412 (2005),<br></p>Formula:C19H19N3O5SColor and Shape:NeatMolecular weight:401.444-Nitro Lenalidomide
CAS:Controlled Product<p>Impurity Lenalidomide impurity<br>Applications Lenalidomide (L328000) analog. Lenalidomide impurity; Lenalidomide intermediate.<br>References Hashimoto, Y., et al.: Bioorg. Med. Chem., 10, 461 (2002),<br></p>Formula:C13H11N3O5Color and Shape:NeatMolecular weight:289.24Pyrimethamine-d3
CAS:Controlled Product<p>Applications Dihydrofolate reductase inhibitor; generally used in combination with other antimicrobial agents. Antiprotozoal (Toxoplasma); antimalarial.<br>References Loutfy, M.A., et al.: Anal. Profiles Drug Subs., 12, 463 (1983), Leport, C., et al.: Am. J. Med., 84, 94 (1988), McIntosh, H.M., et al.: Ann. Trop. Med., Parasitol., 93, 265 (1998), Plowe, C.V., et al.: Br. Med. J., 328, 545 (2004),<br></p>Formula:C12H10D3ClN4Color and Shape:Off-WhiteMolecular weight:251.73L-Phenylacetyl Carbinol
CAS:Controlled Product<p>Applications L-Phenylacetylcarbinol ( (L-PAC) obtained by biotransformation of benzaldehyde.<br>References Ellaiah, P., et al.: Ind. Drugs, 24, 192 (1987), Nikolova, P., et al.: Biotechnol. Bioeng., 38, 493 (1991), Shin, H., et al.: Biotechnol. Bioeng., 49, 52 (1996),<br></p>Formula:C9H10O2Color and Shape:NeatMolecular weight:150.173-(2,4-dimethylphenyl)-2-sulfanylidene-1,2,3,4-tetrahydroquinazolin-4-one
CAS:Purity:98%Molecular weight:282.35998535156255-Methoxy-2-(4-methoxy-3,5-dimethylpyridin-2-yl)-1H-benzo[d]imidazole
CAS:Controlled Product<p>Applications 5-Methoxy-2-(4-methoxy-3,5-dimethylpyridin-2-yl)-1H-benzo[d]imidazole is an impurity of Omeprazole (O635000), which binds covalently to proton pump. It inhibits gastric secretion. Used as an anttiulcerative.<br>References Muller, P., et al.: Arzneimittel-Forsch., 33, 1685 (1983), Wallmark, B., et al.: Biochim. Biophys. Acta., 778, 549 (1984), Morii, M., et al.: J. Biol. chem., 268, 21553 (1993), Ritter, M., et al.: Br. J. Pharmacol., 124, 627 (1998)<br></p>Formula:C16H17N3O2Color and Shape:NeatMolecular weight:283.33Amoxapine-d8
CAS:Controlled ProductFormula:C17H8D8ClN3OColor and Shape:Off White SolidMolecular weight:321.83Rebamipide
CAS:Controlled Product<p>Applications Shows antiulcer activity in rats.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Uchida, M., et al.: Chem. Pharm. Bull., 33, 3775 (1985), Yamasaki, K., et al.: Eur. J. Pharmacol., 142, 23 (1987),<br></p>Formula:C19H15ClN2O4Color and Shape:Off-WhiteMolecular weight:370.79N-Nitroso Varenicline
CAS:Controlled Product<p>Applications N-Nitroso Varenicline is a derivative of Varenicline (V215635(M)), which is a useful medication for smoking cessation.<br>References Hart, E., et al.: Behavioural Brain Research, 397, 112887 (2021)<br></p>Formula:C13H12N4OColor and Shape:NeatMolecular weight:240.2615-(Benzo[1,3]-dioxol-5yl)-picolinic acid
CAS:Purity:95.0%Color and Shape:SolidMolecular weight:243.21800231933594TERT-BUTYL ((4-BROMOTHIOPHEN-2-YL)METHYL)CARBAMATE
CAS:Formula:C10H14BrNO2SPurity:98.0%Color and Shape:SolidMolecular weight:292.192-[5-bromo-2-(pyridin-4-yl)-1H-indol-3-yl]ethan-1-amine hydrochloride
CAS:Purity:95.0%Molecular weight:352.6600036621094(S)-4-Hydroxy Mephenytoin
CAS:Controlled Product<p>Applications The S-enantiomer metabolite of Mephenytoin (M225000).<br>References Boobis, A., et al.: Cancer Res., 54, 89 (1994), Beresford, A., et al.: Xenobiotica, 27, 159 (1997), Zhu, B., et al.: Clin. Pharmacol. Ther., 70, 455 (2001), Jerdi, M., et al.: J. Pharm. Biomed. Anal., 35, 1203 (2004),<br></p>Formula:C12H14N2O3Color and Shape:White To Off-WhiteMolecular weight:234.25N-(1-(2,6-DIFLUOROPHENYL)-1H-PYRAZOL-3-YL)ACETAMIDE
CAS:Purity:95.0%Molecular weight:237.2100067138672α,α,α’,α’-Tetramethyl-5-(dibromomethyl)-1,3-benzenediacetonitrile
CAS:Controlled Product<p>Impurity Anastrozole EP Impurity D / Anastrozole USP Related Compound E<br>Applications α,α,α’,α’-Tetramethyl-5-(dibromomethyl)-1,3-benzenediacetonitrile (Anastrozole EP Impurity D) an impurity of Anastrozole (A637425) (impurity E).<br>References Ge, Z., et al.: J. Med. Chem., 13, 146 (2003),<br></p>Formula:C15H16Br2N2Color and Shape:WhiteMolecular weight:384.11(E)-6-Iodo-3-[2-(pyridin-2-yl)ethenyl]-1-(tetrahydro-2H-pyran-2-yl)-1H-indazole
CAS:Controlled ProductFormula:C19H18IN3OColor and Shape:White To Light YellowMolecular weight:431.272-{[4-methyl-5-(thiophen-2-yl)-4h-1,2,4-triazol-3-yl]sulfanyl}acetic acid
CAS:Purity:95+%Molecular weight:255.3099976Isoleucine Valsartan
CAS:<p>Applications Isoleucine Valsartan is a Valsartan (V095750) impurity. Valsartan is A nonpeptide angiotensin II AT1-receptor antagonist. Antihypertensive.<br>References Criscione, L., et al.: Brit. J. Pharmacol., 110, 761 (1993), Muller, P., et al.: Eur. J. Clin. Pharmacol., 47, 231 (1994)<br></p>Formula:C25H31N5O3Color and Shape:NeatMolecular weight:449.55Telmisartan
CAS:Controlled Product<p>Stability Hygroscopic<br>Applications Telmisartan is an angiotensin II receptor antagonist.<br>References Wienen, W., et al.: Brit. J. Pharmacol., 110, 245 (1993), Neutel, J.M., and Smith, D.H.G.: Adv. Ther., 15, 206 (1998)<br></p>Formula:C33H30N4O2Color and Shape:NeatMolecular weight:514.62(1-Methyl-1H-benzo[d]imidazol-2-yl)(pyridin-4-yl)methanone
CAS:Purity:95.0%Molecular weight:237.26199340820312O-Desmethyl Carvedilol
CAS:Controlled Product<p>Applications A metabolite of Carvedilol (C184625), a nonselective β-adrenergic blocker with α1-blocking activity.<br>References Sponer, G., et al.: J. Cardiovasc. Pharmacol., 9, 317 (1987), Fujimaki, M., et al.: Xenobiotica, 20, 1025 (1990), Ruffolo, R., et al.: Eur. J. Clin. Pharmacol., 38, S82 (1990), Clohs, L., et al.: J. Pharm. Biomed. Anal., 31, 407 (2003),<br></p>Formula:C23H24N2O4Color and Shape:NeatMolecular weight:392.45ABT 199 (>99%)(Venetoclax)
CAS:Controlled Product<p>Applications ABT 199 (>99%) is a potent and selective BCL-2 inhibitor that achieves potent antitumour activity while sparing platelets. It’s practical application is to treat chronic lymphocytic leukaemic cells and estrogen receptor-positive breast cancer.<br>References Davids, M. & Letai, A.: Cancer Cell, 23, 139 (2013); Souers, A.,et al.: Nat. Med., 19, 202 (2013); Vaillant, F., et al.: Cancer Cell, 24, 120 (2013); Vogler, M., et al.: Brit. J. Haematol., 163, 139 (2013);<br></p>Formula:C45H50ClN7O7SColor and Shape:Light Yellow To YellowMolecular weight:868.44Ethyl 3-(2-(chloromethyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate
CAS:Purity:98%Molecular weight:400.85998535156252,3-Dihydro-1-(3-hydroxypropyl)-5-[(2R)-2-[[2-[2-(2,2,2-trifluoroethoxy)phenoxy]ethyl]amino]propyl]
CAS:Controlled Product<p>Applications An impurity in the synthesis of Silodosin (S465000), an α1a-adrenoceptor antagonist. It is used in treatment of benign prostatic hypertophy.<br>References Barve, I. et al.: Tetra., 69, 2834 (2013); Shibata, K., et al.: Mol. Pharmacol., 48, 250 (1995), Murata, S., et al.: J. Urol., 164, 578 (2000),<br></p>Formula:C25H30F3N3O3Color and Shape:Light YellowMolecular weight:477.524-(4-ethoxyphenyl)-3-(pyridin-3-yl)-4,5-dihydro-1H-1,2,4-triazole-5-thione
CAS:Purity:97%Molecular weight:298.35998535156253-Hydroxy Ropivacaine
CAS:Controlled Product<p>Applications A major metabolite of Ropivacaine (R675000).<br>References Ekstrom, G., et al.: Drug Metab. Dispos., 24, 955 (1996), Arvidsson, T., et al.: Biomed. Chromatogr., 13, 286 (1999), Shah, V., et al.: Pharm. Res., 17, 1551 (2000),<br></p>Formula:C17H26N2O2Color and Shape:NeatMolecular weight:290.4rac 8-Hydroxy Efavirenz
CAS:Controlled ProductFormula:C14H9ClF3NO3Color and Shape:NeatMolecular weight:331.67(4-(3-Methoxypropoxy)-3-methylpyridin-2-yl)methanol Hydrochloride
CAS:Controlled ProductFormula:C11H17NO3·HClColor and Shape:NeatMolecular weight:211.26 + 36.46Rilpivirine HCl
CAS:<p>Rilpivirine HCl (Rilpivirine hydrochloride) is an NNRTI inhibitor with antiviral activity that inhibits the HIV virus.</p>Formula:C22H19ClN6Purity:99.48%Color and Shape:SolidMolecular weight:402.885-tert-Butyl-1-(4-nitro-phenyl)-1H-pyrazole-3-carboxylic acid
CAS:Formula:C14H15N3O4Purity:98%Color and Shape:SolidMolecular weight:289.291N-Phenoxycarbonylparoxetine
CAS:Controlled Product<p>Applications N-Phenoxycarbonylparoxetine is an impurity of Paroxetine (P205750), a selective serotonin reuptake inhibitor. Used as an antidepressant.<br>References Lassen, J.B.: Eur. J. Pharmacol., 47, 351 (1978), Lund, J., et al.: Acta Pharmacol. Toxicol., 51, 351, (1982),<br></p>Formula:C26H24FNO5Color and Shape:NeatMolecular weight:449.47(3-Cyclohexyl)propyl 5-(1,3-dioxolan-2-yl)-2-thienyl ketone
CAS:Purity:97.0%Molecular weight:308.44000244140625rac Penbutolol-d9
CAS:Controlled Product<p>Applications Labelled Penbutolol (P220500). A β-adrenoceptor antagonist. Antihypertensive.<br>References Armstrong, D., et al.: Anal. Chem., 66, 1473 (1994), Kato, M., et al.: J. Pharm. Biomed. Anal., 30, 1845 (2003),<br></p>Formula:C18H20D9NO2Color and Shape:White To Off-WhiteMolecular weight:300.484-Demethoxy-4-hydroxy Apixaban
CAS:Controlled Product<p>Applications 4-Demethoxy-4-hydroxy Apixaban is a metabolite of Apixaban (A726700) which is a potent, direct, selective, and orally active inhibitor of coagulation factor Xa.<br>References Luettgen, J.M. et al.: J. Enz. Inhib. Med. Chem., 26, 514 (2011); Glanis, T. et al.: J. Thromb. Thrombol., 31, 310 (2011); barrett, Y.C. et al.: Thromb. Haemos., 105, 181 (2011);<br></p>Formula:C24H23N5O4Color and Shape:NeatMolecular weight:445.47N-Boc-Sitagliptin
CAS:Controlled Product<p>Applications N-Boc-Sitagliptin is the N-Boc protected derivative of Sitagliptin (S490990), a dipeptidyl peptidase-4 inhibitor that is used for glycemic control for patients with type 2 diabetes.<br>References Aschner, P., et al.: Diabetes Care, 29, 2632 (2006); Charbonnel, B., et al.: Diabetes Care, 29, 2638 (2006)<br></p>Formula:C21H23F6N5O3Color and Shape:NeatMolecular weight:507.433-Chloro Cathinone Hydrochloride
CAS:Controlled Product<p>Applications A metabolite of Bupropion (B689625).<br>References Milena, P., et al.: Eur. Congr. Biopharm. Pharmacokinet., 3rd, 2, 313 (1987),<br></p>Formula:C9H11Cl2NOColor and Shape:NeatMolecular weight:220.1O-Desmethyl Felodipine
CAS:Controlled Product<p>Stability Hygroscopic<br>Applications O-Desmethyl metabolite of the calcium channel blocker Felopidine (F232375).<br>References Uno, K. et al.: Yakub. Dotai, 7, 243 (1992);<br></p>Formula:C17H17Cl2NO4Color and Shape:NeatMolecular weight:370.23R-(-)-Deprenyl Hydrochloride
CAS:Controlled Product<p>Applications Monoamine oxidase-B inhibitor related structurally to Pargyline. Used to alleviate the symptoms of Parkinsons disease.<br>References Magyar, K., et al.: Acta Physiol. Acad. Sci. Hung., 32, 377 (1967), Heinonen, E.H., et al.: Acta Neurol. Scand., 84, 44 (1991), Schneider, L.S., et al.: Am. J. Psychiatry, 150, 321 (1993),<br></p>Formula:C13H17N·ClHColor and Shape:White To Off-WhiteMolecular weight:223.74Northiaden
CAS:Controlled Product<p>Applications A metabolite of Dothiepin.<br>References Atkinson, H., et al.: Clin. Pharmacokin., 18, 151 (1990), Hagg, S., et al.: Br. J. Clin. Pharmacol., 49, 286 (2000), Fleishaker, J., et al.: Adv. Drug Deliv. Rev., 55, 643 (2003), Katritzky, A., et al.: Bioorg. Med. Chem., 12, 3027 (2004),<br></p>Formula:C18H19NSColor and Shape:NeatMolecular weight:281.422-Amino-4-isopropylamino-6-chlorotriazine
CAS:Controlled Product<p>Applications Studies have shown compounds of this nature are of pharmacological interest. Also has been shown to inhibit the growth of plants.<br>References Pearlman, W.M., et al.: J.A.C.S. , 70, 3726 (1948), Thurston, J.T., et al.: J.A.C.S., 73, 7, 2981 (1951)<br></p>Formula:C6H10ClN5Color and Shape:Off-WhiteMolecular weight:187.63N-(4-Pyridin-2-yl-thiazol-2-yl)benzene-1,4-diamine
CAS:Color and Shape:SolidMolecular weight:268.33999633789064-Cyano-3-trifluoromethylphenylisothiocyanate
CAS:Controlled ProductFormula:C9H3F3N2SColor and Shape:NeatMolecular weight:228.192-(4-Methyl-2-phenyl-1-piperazinyl)-3-pyridinemethanol
CAS:Controlled Product<p>Applications 2-(4-Methyl-2-phenyl-1-piperazinyl)-3-pyridinemethanol is an impurity found in Mirtazapine (M365000). Mirtazapine Impurity B.<br></p>Formula:C17H21N3OColor and Shape:White To Off-WhiteMolecular weight:283.375,7-dimethyl-N-(pyridin-2-ylmethyl)-1,3-benzothiazol-2-amine
CAS:Purity:95.0%Molecular weight:269.3699951171875O-Desmorpholinopropyl Gefitinib
CAS:<p>Applications A metabolite of Gefitinib.<br>References Ranson, M., et al.: J. Clin. Oncology, 20, 2240 (2002); Mendelsohn, J., et al.: J. Clin. Oncology, 21, 2787 (2003); McKillop, D., et al.: Xenobiotica, 10, 917 (2004);<br></p>Formula:C15H11ClFN3O2Color and Shape:NeatMolecular weight:319.72O-Desisopropyl-O-methoxyethyl Nimodipine
CAS:Controlled Product<p>Impurity Nimodipine EP Impurity C; Nimodipine USP Related Compound B<br>Applications O-Desisopropyl-O-methoxyethyl Nimodipine (Nimodipine EP Impurity C) is an impurity in the synthesis of Nimodipine (A dihydropyridine calcium channel blocker. It is used as a vasodilator (cerebral). Nimodipine USP Related Compound B.<br>References Allen, G.S., et al.: N. Engl. J. Med., 308, 619 (1983), Schluter, H.: Arzneim.-Forsch., 36, 1733 (1986), Deyo, R.A., et al.: Science, 243, 809 (1989),<br></p>Formula:C21H26N2O8Color and Shape:NeatMolecular weight:434.443-Chloro-N-methylpropan-1-amine Hydrochloride
CAS:Controlled Product<p>Applications 3-Chloro-N-methylpropan-1-amine Hydrochloride can be used as reactant/reagent in oxidative metabolism of ferrocene analogs of tamoxifen: characterization and antiproliferative activities of metabolites.<br>References Richard, M. A., et al.: ChemMedChem, 10, 981-990 (2015)<br></p>Formula:C4H10ClN•(HCl)Color and Shape:NeatMolecular weight:107.5836463-Cyclohexyl-6,8-dibromo-3-methyl-1,2,3,4-tetrahydroquinazolinium Chloride
CAS:<p>Impurity Bromhexine EP Impurity E Chloride<br>Applications 3-Cyclohexyl-6,8-dibromo-3-methyl-1,2,3,4-tetrahydroquinazolinium Chloride is an impurity of Bromhexine Hydrochloride (B678600). Bromhexine Hydrochloride impurity E Chloride. Bromhexine is an expectorant; mucolytic.<br>References Goicoechea, H., et al.: Talanta, 49, 793 (1999), Ribone, M., et al.: J. Pharm. Biomed. Anal., 23, 591 (2000),<br></p>Formula:C15H21Br2N2·ClColor and Shape:NeatMolecular weight:424.61Tianeptine
CAS:<p>Applications Tricyclic compound with psychostimulant, anti-ulcer and anti-emetic properties. Antidepressant.<br>References Malen, C., et al.: Experientia, 28, 811 (1972), Safa, A., et al.: J. Biol. Chem., 262, 7884 (1987), Ford, J.M., et al.: Pharmacol. Rev., 42, 155, (1990), Pierre, A., et a.: Cancer Res., 51, 2312 (1991),<br></p>Formula:C21H25ClN2O4SColor and Shape:White To Off-WhiteMolecular weight:436.95Meloxicam- 13CD3
CAS:Controlled Product<p>Applications iMeloxicam- 13CD3 is an isotopic labeled form of Meloxicam(M216100). Meloxicam is a preferential cyclooxygenase (COX-2) inhibitor. Sudoxicam and Meloxicam are nonsteroidal anti-inflammatory drugs (NSAIDs) from the enol-carboxamide class.<br>References Hawkey, C., et al.: Br. J. Rheumatol., 35, Suppl. 1, 1 (1996), Fleischmann, R., et al.: Expert Opin. Pharmacother., 3, 1501 (2002),<br></p>Formula:C1313CH10D3N3O4S2Color and Shape:Off-White To Light BrownMolecular weight:355.41Deoxy Epinephrine Hydrochloride
CAS:Controlled Product<p>Stability Hygroscopic<br>Applications Andregenic and dopamine receptor agonist; active metabolite of Ibopramine (I123500). Also, it is used as internal standard in chromatographic analysis of catecholamines.<br>References Kindler, P., et al.: Arch. Pharm., 270, 340 (1932), Bridgers, W.F., et al.: J. Biol. Chem., 237, 526 (1962),<br></p>Formula:C9H13NO2·ClHColor and Shape:Light Brown To PurpleMolecular weight:203.67Rizatriptan
CAS:<p>Rizatriptan (Risatriptan) is a selective 5-hydroxytryptamine 1B/1D receptor agonist used in the study of migraine.</p>Formula:C15H19N5Purity:99.74%Color and Shape:SolidMolecular weight:269.354-((5,6-Diphenylpyrazin-2-yl)(isopropyl)amino)butan-1-ol
CAS:Purity:98%Molecular weight:361.489013671875Empagliflozin (Tetrahydrofuranyl-d4)
CAS:Controlled Product<p>Applications Empagliflozin-d4 is a labelled analog of Empagliflozin (E521510); a novel, potent and selective SGLT-2 inhibitor, improves glycaemic control and features of metabolic syndrome in diabetic rats.<br>References Thomas, L., et al.: Diabetes. Obesity. Metabol. 14, 94 (2012); Grempler, R., et al.: Diabetes. Obesity. Metabol., 14, 83 (2012);<br></p>Formula:C23D4H23ClO7Color and Shape:NeatMolecular weight:454.934Olanzapine 4'-N-Glucuronide
CAS:Controlled ProductFormula:C23H28N4O6SColor and Shape:NeatMolecular weight:488.557ETHYL 1-CYCLOPROPYL-4-HYDROXY-6-OXO-1,6-DIHYDROPYRIDINE- 3-CARBOXYLATE
CAS:Purity:95.0%Molecular weight:223.22799682617188Dehydro Felodipine Ester Lactone
CAS:Controlled Product<p>Applications A metabolite of Felodipine (F232375).<br>References Wang, S.X. et al.: J. Pharmacol. Exp. Therap., 250, 632 (1989); Baeaernhielm, C. et al.: Drug Metab. Disp., 14, 613 (1986);<br></p>Formula:C17H13Cl2NO4Color and Shape:NeatMolecular weight:366.201-Deoxy-1-(octylamino)-D-glucitol
CAS:Controlled ProductFormula:C14H31NO5Color and Shape:White To Off-WhiteMolecular weight:293.407-chloro-8-methyl-2-pyridin-3-ylquinoline-4-carboxylic acid
CAS:Purity:95.0%Color and Shape:SolidMolecular weight:298.7300109863281Ombitasvir
CAS:Controlled Product<p>Applications Ombitasvir is a pharmaceutical drug that is used in the treatment of hepatitis C virus in patients with HCV genotype 1 infection. It inhibits an important viral phosphoprotein, NS5A, which is involved in viral replication, assembly, and secretion.<br>References Feld, J.J., et al.: New Eng. J. Med., 370, 1594 (2014); Lawitz, E., et al.: J. Hepatol., 57, 24 (2012); Afdhal, N., et al.: New England J. Med., 370, 1889 (2014)<br></p>Formula:C50H67N7O8Color and Shape:NeatMolecular weight:894.114-(2-(Pyridin-2-yl)-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazol-3-yl)quinolin-7-ol
CAS:Purity:95.0%Color and Shape:SolidMolecular weight:328.3754-Phenyl-2-(3-pyridyl)thiazole-5-carboxylic acid
CAS:Color and Shape:SolidMolecular weight:282.320007324218751-Methyl-4-(4-((4-methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)phenyl)carbamoyl)benzyl)piperazine 1-oxide (Imatinib Impurity)
CAS:Purity:98%Molecular weight:509.6142-Amino-4-(3-methoxy-phenyl)-thiophene-3-carboxylic acid methyl ester
CAS:Formula:C13H13NO3SPurity:98%Color and Shape:SolidMolecular weight:263.31N-((2'-(1H-Tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)pentanamide
CAS:Controlled ProductFormula:C19H21N5OColor and Shape:WhiteMolecular weight:335.401,5-Diphenyl-1H-pyrazole-4-carboxylic acid
CAS:Purity:95.0%Color and Shape:SolidMolecular weight:264.283996582031255-(1-Methyl-4-piperidinyl)-5H-dibenzo[a,d]cyclohepten-5-ol
CAS:Controlled Product<p>Applications 5-(1-Methyl-4-piperidinyl)-5H-dibenzo[a,d]cyclohepten-5-ol is a derivative of Cyproheptadine (C989200) which is a first-generation antihistamine with additional anticholinergic, antiserotonergic, and local anesthetic properties. Cyproheptadine is a 5-HT2/5-HT1C serotonin receptor antagonist; H1 histamine receptor antagonist; antipruritic.<br>References Marchei, E., et al.: J. Pharm. Biomed. Anal., 41, 1633 (2006); de-Benedictis, F., et al.: Allergy, 63, 1395 (2008); Feas, X., et al.: J. Pharm. Biomed. Anal., 50, 1044 (2009); Yu, C., et al.: Talanta, 2011, 83, 1376 (2011);<br></p>Formula:C21H23NOColor and Shape:NeatMolecular weight:305.41Varenicline N-Glucoside
CAS:Controlled Product<p>Applications A metabolite of Varenicline. Metabolite M7.<br>References Dow, J., et al.: Drug Metab. Dispos., 22, 738 (1994), Toide, K., et al.: Biochem. Pharmacol., 67, 1269 (2004), Coe, J., et al.: J. Med. Chem., 48, 3474 (2005), Doll, R., et al.: Br. J. Cancer, 92, 426 (2005),<br></p>Formula:C19H23N3O5Color and Shape:NeatMolecular weight:373.40Brexpiprazole S-Oxide
CAS:<p>Applications Brexpiprazole S-Oxide is an impurity and potential metabolite of Brexpiprazole (B677385), a drug candidate useful in treatment and prevention of mental disorders including CNS disorders.<br>References Yamashita, H., et al.: PCT Int. Appl., WO 2006112464 A1 20061026 (2006);<br></p>Formula:C25H27N3O3SColor and Shape:NeatMolecular weight:449.565Hydroxymethyl Ivacaftor
CAS:Controlled Product<p>Applications Hydroxymethyl Ivacaftor is an impurity of Ivacaftor (I940600); a drug used in the treatment of cystic fibrosis.<br>References Clancy, J. et al.: Am. J. Resp. Crit. Care. Med., 186, 593 (2012)<br></p>Formula:C24H28N2O4Color and Shape:NeatMolecular weight:408.49(S,S)Dinitroso Ethambutol
CAS:Controlled ProductFormula:C10H22N4O4Color and Shape:WhiteMolecular weight:262.311-(3-Carboxy-2-pyridyl)-4-methyl-2-phenylpiperazine
CAS:Controlled Product<p>Applications Mirtazapine (M365000) impurity.<br>References Reddy, T. et al.; J. Liq. Chromatogr. R. T. 31, 1204 (2008)<br></p>Formula:C17H19N3O2Color and Shape:NeatMolecular weight:297.35Perphenazine-d4 (phenothiazine-1,3,7,9-d4)
CAS:Controlled Product<p>Applications Perphenazine-d4 (phenothiazine-1,3,7,9-d4) (CAS# 155593-75-2) is a useful isotopically labeled research compound.<br></p>Formula:C21D4H22ClN3OSColor and Shape:NeatMolecular weight:407.994-Fluoro-3-chloroaniline
CAS:Controlled Product<p>Applications 4-Fluoro-3-chloroaniline, is an organic Fluorinated building block used for the synthesis of pharmaceutical and biologically active compounds such as, novel 6-Fluorobenzothiazole-substituted pyrazole analogues, having antiinflammatory activity.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Reddy, D. R. S., et al.: Pharma Chemica., 5, 207 (2013);<br></p>Formula:C6H5ClFNColor and Shape:NeatMolecular weight:145.56N-Formyl Varenicline
CAS:Controlled Product<p>Applications A metabolite of Varenicline. Metabolite M5.<br>References Dow, J., et al.: Drug Metab. Dispos., 22, 738 (1994), Toide, K., et al.: Biochem. Pharmacol., 67, 1269 (2004), Coe, J., et al.: J. Med. Chem., 48, 3474 (2005), Doll, R., et al.: Br. J. Cancer, 92, 426 (2005),<br></p>Formula:C14H13N3OColor and Shape:NeatMolecular weight:239.27Cyamemazine
CAS:<p>Applications Cyamemazine is an anxiolytic antipsychotic, which reduces ethanol withdrawal symptoms.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Robinson, et al.: J. Pharm. Pharmacol., 18, 19 (1966), Miller, L., et al.: J. Pharmacol. Exp. Ther., 246, 170 (1988), Podhorna, J., et al.: Curr. Pharm. Des., 8, 23 (2002), Hameg, A., et al.: Biochem. Pharmacol., 65, 435 (2003),<br></p>Formula:C19H21N3SColor and Shape:Green YellowMolecular weight:323.46Pyrrole-2-carboxaldehyde
CAS:Controlled ProductFormula:C5H5NOColor and Shape:NeatMolecular weight:95.10Clozapine N-Oxide-d8
CAS:Controlled ProductFormula:C18H11D8ClN4OColor and Shape:Yellow To Dark YellowMolecular weight:350.871-[3-(Dimethylamino)propyl]-3-ethylurea
CAS:Controlled Product<p>Applications 1-[3-(Dimethylamino)propyl]-3-ethylurea is a reagent used in the preparation of water soluble, multifunctional antibody-porphyrin gold nanoparticles.<br>References Penon, O. et al.: J. Colloid. Inter. Sci., 496, 100 (2017);<br></p>Formula:C8H19N3OColor and Shape:NeatMolecular weight:173.262-Amino-5-bromo-N-cyclohexyl-N-methylbenzylamine Dihydrochloride
CAS:Controlled Product<p>Impurity Bromhexine EP Impurity D<br>Applications 2-Amino-5-bromo-N-cyclohexyl-N-methylbenzylamine (Bromhexine EP Impurity D) is an impurity of Bromhexine hydrochloride (B678600). Bromhexine hydrochloride impurity D.<br>References Uboh, C.E., et al.: J. Pharmaceut. Biomed. Anal., 9, 33 (19991),<br></p>Formula:C14H21BrN2·2ClHColor and Shape:Light YellowMolecular weight:370.16Cathine Hydrochloride
CAS:Controlled ProductFormula:C9H13NO·ClHColor and Shape:Off-WhiteMolecular weight:187.67
![5-Methoxy-2-(4-methoxy-3,5-dimethylpyridin-2-yl)-1H-benzo[d]imidazole](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FTR%2Fthumb-webp%2FM262960.webp&w=3840&q=75)
![5-(Benzo[1,3]-dioxol-5yl)-picolinic acid](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F10%2Fthumb-webp%2FF044140.webp&w=3840&q=75)
![2-[5-bromo-2-(pyridin-4-yl)-1H-indol-3-yl]ethan-1-amine hydrochloride](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F10%2Fthumb-webp%2FF526136.webp&w=3840&q=75)
![(E)-6-Iodo-3-[2-(pyridin-2-yl)ethenyl]-1-(tetrahydro-2H-pyran-2-yl)-1H-indazole](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FTR%2Fthumb-webp%2FI719515.webp&w=3840&q=75)
![2-{[4-methyl-5-(thiophen-2-yl)-4h-1,2,4-triazol-3-yl]sulfanyl}acetic acid](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F10%2Fthumb-webp%2FF669194.webp&w=3840&q=75)
![(1-Methyl-1H-benzo[d]imidazol-2-yl)(pyridin-4-yl)methanone](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F10%2Fthumb-webp%2FF458070.webp&w=3840&q=75)
![Ethyl 3-(2-(chloromethyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F10%2Fthumb-webp%2FF752907.webp&w=3840&q=75)
![2,3-Dihydro-1-(3-hydroxypropyl)-5-[(2R)-2-[[2-[2-(2,2,2-trifluoroethoxy)phenoxy]ethyl]amino]propyl]](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FTR%2Fthumb-webp%2FD449705.webp&w=3840&q=75)
![4-(2-(Pyridin-2-yl)-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazol-3-yl)quinolin-7-ol](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F10%2Fthumb-webp%2FF321517.webp&w=3840&q=75)
![N-((2'-(1H-Tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)pentanamide](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FTR%2Fthumb-webp%2FT283965.webp&w=3840&q=75)
![5-(1-Methyl-4-piperidinyl)-5H-dibenzo[a,d]cyclohepten-5-ol](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FTR%2Fthumb-webp%2FM321260.webp&w=3840&q=75)
![4-[2-methyl-6-(trifluoromethyl)pyridin-3-yl]pyrimidine-2-thiol](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F10%2Fthumb-webp%2FF518746.webp&w=3840&q=75)
![1-[3-(Dimethylamino)propyl]-3-ethylurea](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FTR%2Fthumb-webp%2FD492553.webp&w=3840&q=75)
